Clinical Trial Update: An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2) [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase umbrella trial (FUTURE-Trop2) in first-line treatment for metastatic triple-negative breast cancer is ongoing, with Phase 1 and Phase 2 components…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN